3.87
+1.42(+57.96%)
Currency In USD
| Previous Close | 2.45 |
| Open | 4.2 |
| Day High | 5.5 |
| Day Low | 3.36 |
| 52-Week High | 15.7 |
| 52-Week Low | 1.72 |
| Volume | 109.43M |
| Average Volume | 1.35M |
| Market Cap | 4.67M |
| PE | -0.33 |
| EPS | -11.65 |
| Moving Average 50 Days | 2.78 |
| Moving Average 200 Days | 3.81 |
| Change | 1.42 |
If you invested $1000 in InMed Pharmaceuticals Inc. (INM) 10 years ago, it would be worth $1.49 as of June 24, 2025 at a share price of $3.51. Whereas If you bought $1000 worth of InMed Pharmaceuticals Inc. (INM) shares 5 years ago, it would be worth $0.99 as of June 24, 2025 at a share price of $3.51.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study
Newsfile
12 hours ago
Demonstrates statistically significant reduction of pro-inflammatory cytokines, including IL-6, IL-1β, IL-2, and KC/GroSignificantly reduces levels of inflammasome marker, NLRP3, a key contributor to neurodegenerationReduces key pro-inflammatory mark
InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest Business, Provides Update on Special Meeting and Makes Modifications to Existing SEPA
Newsfile
Jun 13, 2025 8:30 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - June 13, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases